Pfizer’s newly appointed chief executive officer, Jeffrey B. Kindler, has announced a new leadership organization to streamline the company’s operations and speed decision-making. Mr. Kindler said, “Our new organizational structure builds on the strengths of our company while responding to the accelerating changes in the environment in which we operate. This will put us in the best position to capitalize quickly on the enormous opportunities ahead of us through increasing ...